Details

Autor(en) / Beteiligte

• Pierce, Ellen S.
• Barkhaus, Paul
• Beauchamp, Morgan
• Bromberg, Mark
• Carter, Gregory T.
• Goslinga, Jill
• Greeley, David
• Kihuwa-Mani, Sky
• Levitsky, Gleb
• Lund, Isaac
• McDermott, Christopher
• Pattee, Gary
• Pierce, Kaitlyn
• Polak, Meraida
• Ratner, Dylan
• Wicks, Paul
• Bedlack, Richard

Titel

ALSUntangled #66: antimycobacterial antibiotics

Ist Teil von

• Amyotrophic lateral sclerosis and frontotemporal degeneration, 2023-07, Vol.24 (5-6), p.539-543

Ort / Verlag

England: Taylor & Francis

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Several infections have been associated with motor neuron diseases resembling ALS, including species of viruses, bacteria, and parasites. Mycobacterium avium subspecies paratuberculosis (MAP), most known for its probable etiologic association with Crohn's disease, has been suggested as another possible infectious cause of motor neuron disease. Two published case reports describe the successful treatment of ALS-like symptoms with antimycobacterial antibiotics. Both cases had atypical features. Based on these, we believe it would be reasonable to begin performing chest imaging in PALS who have features of their history or exam that are atypical for ALS such as pain, fevers, or eye movement abnormalities. If the chest imaging is abnormal, more specific testing for mycobacteria may be indicated. Until there is more clear evidence of an association between mycobacteria and ALS, we cannot endorse the widespread use of potentially toxic antimycobacterial antibiotics for PALS.